Matthew H.G. Katz

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Matthew H.G. Katz

Sep 5, 2024, 12:26 | Blog

How does pathologic response following neoadjuvant chemotherapy affect survival/recurrence in PCAD

Anirban Maitra shared on X: "Pathologic complete response following neoadjuvant chemotherapy in Pancreatic Cancer: Impact on…

Aug 9, 2024, 16:38 | Blog

Albert Koong: PFS of 10.3 month vs. 2.5 month in Pancreas Cancer patients with oligometastatic disease

Albert Koong, Division Head and Chair of the Department of Radiation Oncology at MD Anderson…

Aug 8, 2024, 01:43 | Insight

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer - MD Anderson Cancer Center

Approach achieves some of the longest progression-free survival times reported in a clinical trial for…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023